WK5+discu+Post.docx - Post a description of the neurological disorder you selected including types of drugs that would be prescribed to patients to

WK5+discu+Post.docx - Post a description of the...

This preview shows page 1 - 3 out of 5 pages.

Post a description of the neurological disorder you selected including types of drugs that would be prescribed to patients to treat associated symptoms. Then, explain how the factor you selected might impact the effects of prescribed drugs, as well as any measures you might take to help reduce negative side effects. Initial Post Neurological Disorder Arcangelo & Peterson (2013), stated that Major Depressive Disorder (MDD) is the most common mental disorder in the nation and is characterized by changes in cognition, behavior, psychomotor, and physical functioning. The World Health Organization (WHO, 2010) MDD accounts for 3.7% of disabilities in the United States (US) and has been the heaviest burden of disability compared to other behavioral health disorders. In this paper we will discuss the recommended medications to treat MDD, factors that may alter therapeutic response to drug therapy, and the precautions taken to limit negative side effects. Diagnostic Criteria According to the American Psychological Association (2013), criteria for MDD is five or more of the following symptoms have been present for a period of two weeks; depressed mood, lack of interest in regular activities, weight loss or gain, insomnia or oversleeping, psychomotor agitation or slowing, fatigue or lack of energy, worthlessness or excessive guilt, lack of concentration or indecisiveness, and recurrent thought of death or suicidal ideation with or without a plan. These five or more symptoms must cause clinically significant distress in social, occupational, academic, or any other important areas of functioning. The symptoms cannot be attributable to a medical condition or substance abuse. According to the National Institute of
Image of page 1
Health Substance Abuse and Mental Health Services Administration (2017) in 2015, about 16.1 million adults in the U.S. representing 6.7% of all adults in the U.S. had at least one MDD episode.
Image of page 2
Image of page 3

You've reached the end of your free preview.

Want to read all 5 pages?

  • Summer '15
  • Selective serotonin reuptake inhibitor, Major depressive disorder, Arcangelo

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture